PPARA and type 2 diabetes mellitus: Our results of overall and subgroup analysis showed that there were no significant side effects associated with the addition of any PPAR agonist to metformin in patients with type 2 diabetes as compared to metformin, which is contrast to a few studies reporting an increased risk of adverse events associated with the use of PPAR agonists19,58,65,69,70.